Gendoo

MeSH keywords -> Related genes, diseases (OMIM)


Query MeSH keywords list

01 Sex Factors [NCBI]

Gene


 Gene Link Information
Gain		 01



OMIM


 OMIM Link Information
gain		 01
spatial visualization, aptitude for [NCBI] 0.00304956
MAFD2 [NCBI] 0.00181566
VRNI [NCBI] 0.00143553
MVP [NCBI] 0.00141668
immunoglobulin m, level of [NCBI] 0.00137275
PGL2 [NCBI] 0.00137275
MRX1 [NCBI] 0.0012077
MDD [NCBI] 0.00110871
VUR1 [NCBI] 0.00103225
iris pattern [NCBI] 0.000717249
dystelephalangy [NCBI] 0.000717249
nephropathy, progressive, with deafness [NCBI] 0.000717249
striae distensae, familial [NCBI] 0.000717249
muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus [NCBI] 0.000717249
stature quantitative trait locus 7 [NCBI] 0.000717249
tibial torsion, bilateral medial [NCBI] 0.000717249
systemic lupus erythematosus, susceptibility to, 5 [NCBI] 0.000717249
renal failure, progressive, with hypertension [NCBI] 0.000656957
schistosoma mansoni infection, susceptibility/resistance to [NCBI] 0.000656957
aneurysm, intracranial berry, 1 [NCBI] 0.000641466
ANON1 [NCBI] 0.00060202
alport syndrome, autosomal dominant [NCBI] 0.000588229
migraine with or without aura, susceptibility to, 1 [NCBI] 0.000498987
diabetes mellitus, noninsulin-dependent, 4 [NCBI] 0.000456577
acne inversa, familial [NCBI] 0.000456577
asparagus, specific smell hypersensitivity [NCBI] 0.000456577
dyskinesia, familial, with facial myokymia [NCBI] 0.000456577
thrombocytopenia, autosomal recessive [NCBI] 0.000456577
hepatic fibrosis, severe, susceptibility to, due to schistosoma mansoni infection [NCBI] 0.000456577
blue rubber bleb nevus [NCBI] 0.000456577
osteoarthropathy of fingers, familial [NCBI] 0.000456577
AIC [NCBI] 0.000367495
faciodigitogenital syndrome, recessive [NCBI] 0.000361018
camptodactyly [NCBI] 0.000361018
STUT1 [NCBI] 0.000361018
wilms tumor 4 [NCBI] 0.000361018
AUTS7 [NCBI] 0.000361018
nystagmus, voluntary [NCBI] 0.000361018
CVD1 [NCBI] 0.000361018
preauricular fistulae, congenital [NCBI] 0.000361018
APOE [NCBI] 0.000345228
cholesterol level quantitative trait locus 1 [NCBI] 0.000300556
PPPP [NCBI] 0.000300556
oligosynaptic infertility [NCBI] 0.000300556
dupuytren contracture [NCBI] 0.000300556
antipyrine metabolism [NCBI] 0.000300556
eosinophilia, familial [NCBI] 0.000300556
autism [NCBI] 0.000298079
IS1 [NCBI] 0.000288342
PRL [NCBI] 0.000283504
lymphedema, microcephaly, chorioretinopathy syndrome [NCBI] 0.000256763
FECD2 [NCBI] 0.000256763
torus palatinus and torus mandibularis [NCBI] 0.000256763
EFMR [NCBI] 0.000256763
hypertelorism, teebi type [NCBI] 0.000256763
splenic hypoplasia [NCBI] 0.000256763
diabetes mellitus, insulin-dependent, x-linked, susceptibility to [NCBI] 0.000256763
ETM2 [NCBI] 0.000256763
letterer-siwe disease [NCBI] 0.000256763
trichoepithelioma, multiple familial [NCBI] 0.000222789
STHAG4 [NCBI] 0.000222789
beta-aminoisobutyric acid, urinary excretion of [NCBI] 0.000195302
cluster headache, familial [NCBI] 0.000195302
ASD1 [NCBI] 0.000195302
acrodysostosis [NCBI] 0.000195302
ocular motor apraxia [NCBI] 0.000195302
acetabular dysplasia [NCBI] 0.000195302
hodgkin disease, x-linked pseudoautosomal [NCBI] 0.000195302
PHP [NCBI] 0.000195302
QPD [NCBI] 0.000195302
nephrolithiasis, calcium oxalate [NCBI] 0.000195302
AD [NCBI] 0.000190021
COMT [NCBI] 0.000187132
CPI [NCBI] 0.000183617
CF [NCBI] 0.000180286
OFC1 [NCBI] 0.000174813
GTS [NCBI] 0.000173029
CGF [NCBI] 0.000172426
neuroticism [NCBI] 0.000172426
MTACR1 [NCBI] 0.000172426
strabismus, susceptibility to [NCBI] 0.000172426
robinow syndrome, autosomal dominant [NCBI] 0.000172426
AUTS9 [NCBI] 0.000172426
aortic aneurysm, abdominal [NCBI] 0.000170631
PCD [NCBI] 0.000156577
IGES [NCBI] 0.000152998
SRS [NCBI] 0.000152985
CRC [NCBI] 0.000150103
BULN1 [NCBI] 0.000136247
polydactyly, postaxial, type a1 [NCBI] 0.00012775
HD [NCBI] 0.000126849
CCAL2 [NCBI] 0.000121865
ETM1 [NCBI] 0.000121865
WDM [NCBI] 0.000121634
OTSC1 [NCBI] 0.000121634
sjogren syndrome [NCBI] 0.000121634
AUTS6 [NCBI] 0.000121634
ATS [NCBI] 0.000118843
MG [NCBI] 0.000118482
TNF [NCBI] 0.000111997
urogenital adysplasia, hereditary [NCBI] 0.000111828
alcohol dependence [NCBI] 0.00011119
CFNS [NCBI] 0.000107989
resting heart rate [NCBI] 0.000105377
varicose veins [NCBI] 0.000105377
IBGC1 [NCBI] 9.73593e-05
cd4/cd8 t-cell ratio [NCBI] 9.3878e-05
h-y antigen receptor [NCBI] 9.3878e-05
carney triad [NCBI] 9.3878e-05
HFE [NCBI] 9.32898e-05
MAOA [NCBI] 9.18807e-05
leber optic atrophy, susceptibility to [NCBI] 8.71805e-05
temporal arteritis [NCBI] 8.70565e-05
hemoglobin, high oxygen saturation of [NCBI] 8.0084e-05
mycosis fungoides [NCBI] 8.0084e-05
proteolytic capacity of plasma [NCBI] 8.0084e-05
anus, imperforate [NCBI] 8.0084e-05
pachydermodactyly, familial [NCBI] 8.0084e-05
bladder diverticulum [NCBI] 8.0084e-05
puerto rican infant hypotonia syndrome [NCBI] 8.0084e-05
renal tubular acidosis, proximal [NCBI] 8.0084e-05
porokeratosis plantaris, palmaris, et disseminata [NCBI] 8.0084e-05
celiac artery stenosis from compression by median arcuate ligament of diaphragm [NCBI] 8.0084e-05
microcornea, glaucoma, and absent frontal sinuses [NCBI] 8.0084e-05
low density lipoprotein cholesterol, mild elevation of [NCBI] 8.0084e-05
low density lipoprotein, variation in molecular weight of [NCBI] 8.0084e-05
SHBG [NCBI] 7.88216e-05
LFS1 [NCBI] 7.87313e-05
legg-calve-perthes disease [NCBI] 7.81348e-05
twinning, dizygotic [NCBI] 7.80565e-05
PAND1 [NCBI] 7.80565e-05
FA [NCBI] 7.41254e-05
AIH2 [NCBI] 7.22792e-05
faciogenital dysplasia [NCBI] 7.17816e-05
fabry disease [NCBI] 7.01743e-05
panencephalitis, subacute sclerosing [NCBI] 6.63249e-05
GBD1 [NCBI] 6.28968e-05
cayler cardiofacial syndrome [NCBI] 6.24354e-05
SCZD [NCBI] 5.99307e-05
HTX1 [NCBI] 5.90303e-05
OCD1 [NCBI] 5.90303e-05
neural tube defects [NCBI] 5.85549e-05
PSORS1 [NCBI] 5.74559e-05
NS1 [NCBI] 5.64722e-05
abdominal obesity-metabolic syndrome [NCBI] 5.57299e-05
IGAN1 [NCBI] 5.57299e-05
amyloidosis, primary cutaneous [NCBI] 5.55706e-05
MRXS13 [NCBI] 5.55706e-05
HOMG [NCBI] 5.55706e-05
abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism [NCBI] 5.55706e-05
IP [NCBI] 5.50075e-05
CAT [NCBI] 5.46788e-05
CYP1A1 [NCBI] 5.4306e-05
MAFD1 [NCBI] 5.41696e-05
geographic tongue and fissured tongue [NCBI] 5.26813e-05
genu valgum, st. helena familial [NCBI] 5.26813e-05
xh antigen [NCBI] 5.26813e-05
cerebrocortical degeneration of infancy [NCBI] 5.26813e-05
athrombia, essential [NCBI] 5.26813e-05
hernia, anterior diaphragmatic [NCBI] 5.26813e-05
muscular dystrophy, scapulohumeral [NCBI] 5.26813e-05
aarskog syndrome [NCBI] 5.26813e-05
pulmonary hypertension, primary, autosomal recessive [NCBI] 5.26813e-05
hyperostosis frontalis interna [NCBI] 5.26813e-05
CMD3B [NCBI] 5.24463e-05
XFS [NCBI] 5.24463e-05
PON1 [NCBI] 5.15507e-05
BGLAP [NCBI] 5.12998e-05
AK1 [NCBI] 5.11348e-05
lymphoma, non-hodgkin, familial [NCBI] 5.04101e-05
PGL1 [NCBI] 5.0011e-05
kaposi sarcoma [NCBI] 4.96031e-05
leber optic atrophy [NCBI] 4.95387e-05
WAS [NCBI] 4.76757e-05
GNRH1 [NCBI] 4.76183e-05
danubian endemic familial nephropathy [NCBI] 4.75561e-05
HMS1 [NCBI] 4.69992e-05
PI [NCBI] 4.65928e-05
CFTR [NCBI] 4.59402e-05
LPL [NCBI] 4.53252e-05
VEGF [NCBI] 4.4948e-05
MAFD6 [NCBI] 4.48587e-05
porphyria variegata [NCBI] 4.47739e-05
IDDM [NCBI] 4.4611e-05
ASPS [NCBI] 4.46014e-05
AR [NCBI] 4.4492e-05
CVID [NCBI] 4.32386e-05
polydactyly [NCBI] 4.25694e-05
arcus corneae [NCBI] 4.25694e-05
FECD1 [NCBI] 4.25694e-05
mydriatic response to pharmacologic agents [NCBI] 4.25694e-05
dermatitis herpetiformis, familial [NCBI] 4.25694e-05
pernicious anemia [NCBI] 4.25694e-05
earlobe attachment: attached vs unattached [NCBI] 4.25694e-05
brugada syndrome 2 [NCBI] 4.25694e-05
mass syndrome [NCBI] 4.25694e-05
glutamate monosodium sensitivity [NCBI] 4.25694e-05
periodontitis, aggressive, 1 [NCBI] 4.23828e-05
neural tube defects, folate-sensitive [NCBI] 4.23828e-05
PTH [NCBI] 4.21416e-05
SCA1 [NCBI] 4.14568e-05
POAG [NCBI] 4.05383e-05
hypophosphatemic rickets, x-linked dominant [NCBI] 4.05383e-05
CMM [NCBI] 4.04672e-05
menkes disease [NCBI] 4.02107e-05
amyloidosis vi [NCBI] 4.00296e-05
KLK3 [NCBI] 3.99898e-05
ADHD [NCBI] 3.86974e-05
EGF [NCBI] 3.84346e-05
APOB [NCBI] 3.64209e-05
methane production [NCBI] 3.6133e-05
HAE III [NCBI] 3.6133e-05
cyanide, inability to smell [NCBI] 3.6133e-05
australia antigen [NCBI] 3.6133e-05
trigonocephaly, nonsyndromic [NCBI] 3.6133e-05
respiratory underresponsiveness to hypoxia and hypercapnia [NCBI] 3.6133e-05
buruli ulcer, susceptibility to [NCBI] 3.6133e-05
polydactyly, preaxial i [NCBI] 3.6133e-05
antisense igf2r [NCBI] 3.6133e-05
myxoma, intracardiac [NCBI] 3.6133e-05
FSHMD1A [NCBI] 3.58599e-05
AS [NCBI] 3.56017e-05
SMAX1 [NCBI] 3.46074e-05
diaphragmatic hernia, congenital [NCBI] 3.45637e-05
HP [NCBI] 3.45174e-05
LWD [NCBI] 3.40549e-05
G6PD [NCBI] 3.39573e-05
CMT1B [NCBI] 3.30896e-05
TG [NCBI] 3.30058e-05
DRD4 [NCBI] 3.24792e-05
RP [NCBI] 3.21839e-05
LNS [NCBI] 3.21534e-05
hodgkin lymphoma [NCBI] 3.18365e-05
DRD [NCBI] 3.18365e-05
SERPINA6 [NCBI] 3.1498e-05
sea-blue histiocyte disease [NCBI] 3.1442e-05
earlobe crease [NCBI] 3.1442e-05
aromatic l-amino acid decarboxylase deficiency [NCBI] 3.1442e-05
chorioretinal dysplasia-microcephaly-mental retardation syndrome [NCBI] 3.1442e-05
FCDT [NCBI] 3.1442e-05
gout, hprt-related [NCBI] 3.1442e-05
robinow-sorauf syndrome [NCBI] 3.1442e-05
macrocephaly, benign familial [NCBI] 3.1442e-05
isoproterenol-mediated vasodilatation [NCBI] 3.1442e-05
SCZD8 [NCBI] 3.1442e-05
renal tubular acidosis, proximal, with ocular abnormalities and mental retardation [NCBI] 3.1442e-05
obesity [NCBI] 3.1245e-05
thrombocytopenic purpura, autoimmune [NCBI] 3.07495e-05
AIG1 [NCBI] 3.06556e-05
hashimoto thyroiditis [NCBI] 3.04224e-05
ZIC3 [NCBI] 2.94933e-05
POU3F4 [NCBI] 2.94933e-05
thiourea tasting [NCBI] 2.909e-05
AHC [NCBI] 2.909e-05
DYX1 [NCBI] 2.78244e-05
scapuloperoneal syndrome, neurogenic, kaeser type [NCBI] 2.77792e-05
HDL2 [NCBI] 2.77792e-05
HPE4 [NCBI] 2.77792e-05
hyperalphalipoproteinemia [NCBI] 2.77792e-05
glaucoma, normal tension, susceptibility to [NCBI] 2.77792e-05
DFNA20 [NCBI] 2.77792e-05
intestinal pseudoobstruction, neuronal, chronic idiopathic, x-linked [NCBI] 2.77792e-05
HFM [NCBI] 2.74339e-05
NGFB [NCBI] 2.5798e-05
musical perfect pitch [NCBI] 2.54813e-05
HSAS [NCBI] 2.54813e-05
TBG [NCBI] 2.54301e-05
ADRB1 [NCBI] 2.51986e-05
TPH1 [NCBI] 2.51986e-05
DSAP1 [NCBI] 2.47957e-05
ectodermal dysplasia, anhidrotic [NCBI] 2.47957e-05
hypotrichosis simplex of scalp [NCBI] 2.47957e-05
thyrotoxic periodic paralysis [NCBI] 2.47957e-05
F5F8D [NCBI] 2.47957e-05
pneumothorax, primary spontaneous [NCBI] 2.47957e-05
VIP [NCBI] 2.4752e-05
AGT [NCBI] 2.45032e-05
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i [NCBI] 2.43945e-05
TSIX [NCBI] 2.38644e-05
DRD2 [NCBI] 2.33537e-05
PGD [NCBI] 2.26786e-05
HEMB [NCBI] 2.26308e-05
congenital hemidysplasia with ichthyosiform erythroderma and limb defects [NCBI] 2.22951e-05
OPLL [NCBI] 2.22951e-05
vitiligo [NCBI] 2.22951e-05
creatine deficiency syndrome, x-linked [NCBI] 2.22951e-05
hypertriglyceridemia, familial [NCBI] 2.22951e-05
HYR [NCBI] 2.22951e-05
ehlers-danlos syndrome, type iii [NCBI] 2.22951e-05
deafness, aminoglycoside-induced [NCBI] 2.22951e-05
PCNA [NCBI] 2.10115e-05
HGF [NCBI] 2.07821e-05
HSR [NCBI] 2.06455e-05
CYP11B1 [NCBI] 2.06455e-05
BDNF [NCBI] 2.02226e-05
OPTA2 [NCBI] 2.01554e-05
aspirin resistance [NCBI] 2.01554e-05
tobacco addiction, susceptibility to [NCBI] 2.01554e-05
NPHP3 [NCBI] 2.01554e-05
VLDLRCH [NCBI] 2.01554e-05
elliptocytosis, rhesus-unlinked type [NCBI] 2.01554e-05
PDP [NCBI] 2.01554e-05
HES [NCBI] 2.01554e-05
HBFQTL2 [NCBI] 2.01504e-05
restless legs syndrome, susceptibility to, 1 [NCBI] 2.01504e-05
HS1BP3 [NCBI] 1.9364e-05
CUTL2 [NCBI] 1.9364e-05
CES3 [NCBI] 1.9364e-05
GPR78 [NCBI] 1.9364e-05
ERDA1 [NCBI] 1.9364e-05
HSF2 [NCBI] 1.9364e-05
VDR [NCBI] 1.93605e-05
OCA2 [NCBI] 1.88387e-05
TFF1 [NCBI] 1.85651e-05
UCP1 [NCBI] 1.8331e-05
17-@beta hydroxysteroid dehydrogenase iii deficiency [NCBI] 1.8296e-05
LISX1 [NCBI] 1.8296e-05
BRIC1 [NCBI] 1.8296e-05
LGMD2E [NCBI] 1.8296e-05
HCHWAD [NCBI] 1.8296e-05
alport syndrome, autosomal recessive [NCBI] 1.8296e-05
FMD [NCBI] 1.8296e-05
SLOS [NCBI] 1.82672e-05
SMA3 [NCBI] 1.8048e-05
PJS [NCBI] 1.80188e-05
MECP2 [NCBI] 1.75727e-05
CPEB1 [NCBI] 1.73769e-05
GPD1L [NCBI] 1.73769e-05
COL8A2 [NCBI] 1.73769e-05
lactase persistence [NCBI] 1.72901e-05
MAOB [NCBI] 1.7165e-05
SAA1 [NCBI] 1.68441e-05
IRID1 [NCBI] 1.66605e-05
PFHB1A [NCBI] 1.66605e-05
GLC1A [NCBI] 1.65631e-05
alopecia, androgenetic [NCBI] 1.65256e-05
INS [NCBI] 1.62818e-05
STAT5B [NCBI] 1.62328e-05
PTK2 [NCBI] 1.62092e-05
PLTP [NCBI] 1.6055e-05
coproporphyria [NCBI] 1.59412e-05
ZDHHC8 [NCBI] 1.59081e-05
PRKAR1B [NCBI] 1.59081e-05
MANBA [NCBI] 1.59081e-05
TSTA3 [NCBI] 1.59081e-05
ARID5B [NCBI] 1.59081e-05
TLX2 [NCBI] 1.59081e-05
SIM1 [NCBI] 1.59081e-05
growth hormone insensitivity syndrome [NCBI] 1.58654e-05
ALB [NCBI] 1.56562e-05
SLC6A3 [NCBI] 1.55188e-05
PEMT [NCBI] 1.53836e-05
AFP [NCBI] 1.52818e-05
THC1 [NCBI] 1.52079e-05
MTC [NCBI] 1.52079e-05
plasminogen deficiency, type i [NCBI] 1.52079e-05
hyperlipoproteinemia, type ii [NCBI] 1.52079e-05
LGMD2H [NCBI] 1.52079e-05
encephalopathy, neonatal severe, due to mecp2 mutations [NCBI] 1.52079e-05
CMT4A [NCBI] 1.52079e-05
CYLD [NCBI] 1.52079e-05
pycnodysostosis [NCBI] 1.52079e-05
HPE2 [NCBI] 1.52079e-05
IHPS1 [NCBI] 1.52079e-05
LEPR [NCBI] 1.5158e-05
HNMT [NCBI] 1.51168e-05
AIS [NCBI] 1.51012e-05
MS [NCBI] 1.50909e-05
APC [NCBI] 1.49635e-05
CRH [NCBI] 1.4911e-05
SCAMP1 [NCBI] 1.47447e-05
FUCA2 [NCBI] 1.47447e-05
IGER [NCBI] 1.45519e-05
GLA [NCBI] 1.41204e-05
AT [NCBI] 1.40253e-05
wolff-parkinson-white syndrome [NCBI] 1.39077e-05
chondrodysplasia punctata, autosomal dominant [NCBI] 1.39077e-05
OPD1 [NCBI] 1.39077e-05
adrenal hyperplasia, congenital, due to steroid 11-beta-hydroxylase deficiency [NCBI] 1.39077e-05
CDGG1 [NCBI] 1.39077e-05
cutis laxa, autosomal recessive, type ii [NCBI] 1.39077e-05
WS2A [NCBI] 1.39077e-05
autoimmune disease [NCBI] 1.39077e-05
amyloidosis v [NCBI] 1.39077e-05
acyl-coa dehydrogenase, short-chain, deficiency of [NCBI] 1.39077e-05
sacral defect with anterior meningocele [NCBI] 1.39077e-05
CPB2 [NCBI] 1.39075e-05
CEACAM5 [NCBI] 1.38075e-05
AMH [NCBI] 1.37833e-05
PPP1R3A [NCBI] 1.3783e-05
MMP8 [NCBI] 1.3783e-05
PRB2 [NCBI] 1.3783e-05
CD [NCBI] 1.36665e-05
porphyria cutanea tarda [NCBI] 1.34389e-05
APCS [NCBI] 1.32228e-05
TSC1 [NCBI] 1.32228e-05
PTPRG [NCBI] 1.29646e-05
NNT [NCBI] 1.29646e-05
CHIT1 [NCBI] 1.29646e-05
EED [NCBI] 1.29646e-05
complement component 8 deficiency, type ii [NCBI] 1.29646e-05
ATP10A [NCBI] 1.29646e-05
VTN [NCBI] 1.29646e-05
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency [NCBI] 1.29153e-05
RTT [NCBI] 1.28134e-05
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1 [NCBI] 1.27364e-05
tetralogy of fallot [NCBI] 1.27364e-05
mucopolysaccharidosis type iiic [NCBI] 1.27364e-05
pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities [NCBI] 1.27364e-05
diabetes mellitus, insulin-resistant, with acanthosis nigricans [NCBI] 1.27364e-05
sitosterolemia [NCBI] 1.27364e-05
SCZD9 [NCBI] 1.27364e-05
asplenia with cardiovascular anomalies [NCBI] 1.27364e-05
HSCR2 [NCBI] 1.27364e-05
holoprosencephaly [NCBI] 1.25515e-05
palatopharyngeal incompetence [NCBI] 1.25515e-05
GHRH [NCBI] 1.24335e-05
isoniazid inactivation [NCBI] 1.24082e-05
ABCG8 [NCBI] 1.22535e-05
ABCA2 [NCBI] 1.22535e-05
CYSLTR1 [NCBI] 1.22535e-05
EDNRA [NCBI] 1.22535e-05
GNAL [NCBI] 1.22535e-05
SDC3 [NCBI] 1.22535e-05
BSCL2 [NCBI] 1.22535e-05
F13A1 [NCBI] 1.2216e-05
CFB [NCBI] 1.2216e-05
IGHG1 [NCBI] 1.2216e-05
HPRT1 [NCBI] 1.22049e-05
MODY [NCBI] 1.2193e-05
hypophosphatasia, adult type [NCBI] 1.16754e-05
myasthenic syndrome, congenital, associated with episodic apnea [NCBI] 1.16754e-05
MTS [NCBI] 1.16754e-05
nondisjunction [NCBI] 1.16754e-05
gilbert syndrome [NCBI] 1.16754e-05
chromosome 5q deletion syndrome [NCBI] 1.16754e-05
HPE3 [NCBI] 1.16754e-05
HAL [NCBI] 1.16256e-05
GRHL3 [NCBI] 1.16256e-05
PGM1 [NCBI] 1.1488e-05
A2M [NCBI] 1.1488e-05
von willebrand disease [NCBI] 1.14463e-05
BCHE [NCBI] 1.13572e-05
PRB1 [NCBI] 1.10641e-05
PEPC [NCBI] 1.10641e-05
FMR1 [NCBI] 1.09197e-05
galactosemia [NCBI] 1.06871e-05
MTND4 [NCBI] 1.06599e-05
FTD [NCBI] 1.06133e-05
CRHR2 [NCBI] 1.0557e-05
ADH3 [NCBI] 1.0557e-05
SOAT1 [NCBI] 1.0557e-05
TYMS [NCBI] 1.05511e-05
DDC [NCBI] 1.05482e-05
ITGB3 [NCBI] 1.05039e-05
phenylketonuria [NCBI] 1.04188e-05
CYP19A1 [NCBI] 1.0351e-05
NF2 [NCBI] 1.02146e-05
sickle cell anemia [NCBI] 1.02146e-05
PLG [NCBI] 1.01427e-05
SULT1A1 [NCBI] 1.00952e-05
SLC6A4 [NCBI] 1.00237e-05
diarrhea 1, secretory chloride, congenital [NCBI] 9.82842e-06
diabetes-deafness syndrome, maternally transmitted [NCBI] 9.82842e-06
longevity [NCBI] 9.82842e-06
mucopolysaccharidosis type iiia [NCBI] 9.82842e-06
TMAU [NCBI] 9.82842e-06
NPHS1 [NCBI] 9.82842e-06
LDLR [NCBI] 9.80685e-06
MTHFD1 [NCBI] 9.67158e-06
ACTG1 [NCBI] 9.67158e-06
BLMH [NCBI] 9.67158e-06
TPH2 [NCBI] 9.67158e-06
NPAS2 [NCBI] 9.67158e-06
XG [NCBI] 9.67158e-06
PDE4D [NCBI] 9.67158e-06
OLR1 [NCBI] 9.67158e-06
HSCR1 [NCBI] 9.5194e-06
GC [NCBI] 9.46839e-06
HIC1 [NCBI] 9.28076e-06
LU [NCBI] 9.28076e-06
OGG1 [NCBI] 9.28076e-06
SPAM1 [NCBI] 9.28076e-06
APOC3 [NCBI] 9.28076e-06
PRH1 [NCBI] 9.28076e-06
HABP2 [NCBI] 9.28076e-06
properdin deficiency, x-linked [NCBI] 9.02055e-06
APRT [NCBI] 8.98465e-06
TBX21 [NCBI] 8.91834e-06
ME2 [NCBI] 8.91834e-06
PFC [NCBI] 8.91834e-06
LEP [NCBI] 8.65742e-06
CD99 [NCBI] 8.58076e-06
THBD [NCBI] 8.58076e-06
CYP1A2 [NCBI] 8.58076e-06
GIST [NCBI] 8.4991e-06
ED1 [NCBI] 8.49172e-06
MPO [NCBI] 8.39081e-06
brugada syndrome 1 [NCBI] 8.27826e-06
KAL2 [NCBI] 8.27826e-06
AIED [NCBI] 8.27826e-06
HNA [NCBI] 8.27826e-06
pancreatic carcinoma [NCBI] 8.27826e-06
GNB3 [NCBI] 8.26509e-06
FGB [NCBI] 8.26509e-06
KEL [NCBI] 8.26509e-06
GJA4 [NCBI] 8.26509e-06
MTR [NCBI] 8.02257e-06
RAF1 [NCBI] 7.9689e-06
JK [NCBI] 7.9689e-06
NRIP1 [NCBI] 7.9689e-06
NF1 [NCBI] 7.89617e-06
KSS [NCBI] 7.82452e-06
hemophilia a [NCBI] 7.70704e-06
PTPN22 [NCBI] 7.69013e-06
COL11A2 [NCBI] 7.69013e-06
SLC6A8 [NCBI] 7.69013e-06
FUT2 [NCBI] 7.69013e-06
SGCE [NCBI] 7.69013e-06
KCNJ2 [NCBI] 7.69013e-06
KRIT1 [NCBI] 7.69013e-06
polycythemia vera [NCBI] 7.59464e-06
KTCN1 [NCBI] 7.59464e-06
GALK1 [NCBI] 7.42703e-06
TFPI [NCBI] 7.24406e-06
HAMP [NCBI] 7.17812e-06
DCX [NCBI] 7.17812e-06
DBA [NCBI] 7.07092e-06
HBB [NCBI] 7.03334e-06
LQT1 [NCBI] 7.00683e-06
ARMD1 [NCBI] 7.00683e-06
ichthyosis, x-linked [NCBI] 6.99817e-06
histidinemia [NCBI] 6.96382e-06
CDPX1 [NCBI] 6.96382e-06
GHSR [NCBI] 6.9421e-06
ASIP [NCBI] 6.9421e-06
MPL [NCBI] 6.9421e-06
hla-d histocompatibility type [NCBI] 6.77994e-06
RHD [NCBI] 6.71785e-06
F3 [NCBI] 6.69655e-06
ACH [NCBI] 6.65295e-06
homocystinuria [NCBI] 6.62968e-06
DRPLA [NCBI] 6.50438e-06
SMS [NCBI] 6.46329e-06
OXT [NCBI] 6.43854e-06
ehlers-danlos syndrome, type i [NCBI] 6.38077e-06
fraser syndrome [NCBI] 6.38077e-06
TF [NCBI] 6.33623e-06
CRP [NCBI] 6.30084e-06
HLA-DRB1 [NCBI] 6.30084e-06
GAPDH [NCBI] 6.23315e-06
MBP [NCBI] 6.15897e-06
RBP3 [NCBI] 6.10647e-06
TLR4 [NCBI] 6.06057e-06
NPPA [NCBI] 5.9714e-06
AHSG [NCBI] 5.92057e-06
IL4R [NCBI] 5.92057e-06
ADH2 [NCBI] 5.92057e-06
sudden infant death syndrome [NCBI] 5.84113e-06
DYT1 [NCBI] 5.74254e-06
IFNGR1 [NCBI] 5.74254e-06
GPX1 [NCBI] 5.74254e-06
hemophagocytic lymphohistiocytosis, familial, 1 [NCBI] 5.67475e-06
ARX [NCBI] 5.57185e-06
PG [NCBI] 5.56682e-06
CP [NCBI] 5.44299e-06
TD1 [NCBI] 5.43594e-06
CMH [NCBI] 5.41732e-06
HSPB1 [NCBI] 5.408e-06
CHGA [NCBI] 5.408e-06
GSTP1 [NCBI] 5.408e-06
DHH [NCBI] 5.408e-06
DISC1 [NCBI] 5.408e-06
glycogen storage disease v [NCBI] 5.34113e-06
EFE [NCBI] 5.34113e-06
DPYD [NCBI] 5.25056e-06
COL4A5 [NCBI] 5.25056e-06
RBP4 [NCBI] 5.25056e-06
STAT4 [NCBI] 5.25056e-06
APOH [NCBI] 5.25056e-06
ATXN1 [NCBI] 5.25056e-06
PRODH [NCBI] 5.25056e-06
CTGF [NCBI] 5.19847e-06
ornithine transcarbamylase deficiency, hyperammonemia due to [NCBI] 5.15561e-06
MEN2A [NCBI] 5.15561e-06
PTPN11 [NCBI] 5.09911e-06
IGF1R [NCBI] 5.09911e-06
MEFV [NCBI] 5.09911e-06
MTRNR1 [NCBI] 5.09911e-06
MTND6 [NCBI] 4.9533e-06
RNASE3 [NCBI] 4.90358e-06
NEM3 [NCBI] 4.87747e-06
FDH [NCBI] 4.87747e-06
CPX [NCBI] 4.87747e-06
gaucher disease, type iii [NCBI] 4.87747e-06
OCRL [NCBI] 4.87747e-06
PDB [NCBI] 4.87747e-06
IL5 [NCBI] 4.81279e-06
CLCN1 [NCBI] 4.81279e-06
GRPR [NCBI] 4.81279e-06
EWSR1 [NCBI] 4.81279e-06
CNTF [NCBI] 4.79066e-06
GSN [NCBI] 4.67729e-06
FMO3 [NCBI] 4.67729e-06
VHL [NCBI] 4.66423e-06
GJB1 [NCBI] 4.61182e-06
IGKC [NCBI] 4.54651e-06
aspartylglucosaminuria [NCBI] 4.54651e-06
ICAM1 [NCBI] 4.54651e-06
ACE [NCBI] 4.44925e-06
SMA2 [NCBI] 4.44723e-06
lung cancer [NCBI] 4.44723e-06
pheochromocytoma [NCBI] 4.44723e-06
osteoarthritis [NCBI] 4.44723e-06
hepatocellular carcinoma [NCBI] 4.44723e-06
MYO7A [NCBI] 4.42019e-06
EPO [NCBI] 4.34773e-06
ornithine aminotransferase deficiency [NCBI] 4.29812e-06
ALDH2 [NCBI] 4.29812e-06
glycogen storage disease i [NCBI] 4.29812e-06
LTA [NCBI] 4.29812e-06
BGN [NCBI] 4.29812e-06
IGFALS [NCBI] 4.19463e-06
RS1 [NCBI] 4.18005e-06
SHOX [NCBI] 4.18005e-06
RB1 [NCBI] 4.1599e-06
TS [NCBI] 4.15563e-06
RHCE [NCBI] 4.0658e-06
GAMT [NCBI] 4.0658e-06
C4B [NCBI] 4.0658e-06
XDH [NCBI] 4.05795e-06
RET [NCBI] 3.97199e-06
DES [NCBI] 3.95518e-06
ATP7B [NCBI] 3.95518e-06
EDN1 [NCBI] 3.95518e-06
FY [NCBI] 3.95518e-06
GRN [NCBI] 3.95518e-06
TTR [NCBI] 3.91921e-06
SLPI [NCBI] 3.91802e-06
hypertension, essential [NCBI] 3.90407e-06
ALS1 [NCBI] 3.90407e-06
BRCA2 [NCBI] 3.86469e-06
PDHA1 [NCBI] 3.84802e-06
protoporphyria, erythropoietic [NCBI] 3.84802e-06
H19 [NCBI] 3.84802e-06
TCRG [NCBI] 3.74415e-06
POF1 [NCBI] 3.67701e-06
usher syndrome, type i [NCBI] 3.67701e-06
PPSH [NCBI] 3.67701e-06
AVP [NCBI] 3.66741e-06
LPA [NCBI] 3.64343e-06
GRIA1 [NCBI] 3.64343e-06
ADIPOQ [NCBI] 3.64343e-06
CCK [NCBI] 3.60855e-06
FFI [NCBI] 3.52366e-06
fragile x mental retardation syndrome [NCBI] 3.52025e-06
IBD1 [NCBI] 3.46799e-06
DAZ [NCBI] 3.45087e-06
GSR [NCBI] 3.45087e-06
KAL1 [NCBI] 3.45087e-06
CBX5 [NCBI] 3.41265e-06
SPP1 [NCBI] 3.4046e-06
VLDLR [NCBI] 3.35878e-06
pyruvate decarboxylase deficiency [NCBI] 3.33271e-06
apert syndrome [NCBI] 3.33271e-06
alzheimer disease 3 [NCBI] 3.33271e-06
MFS [NCBI] 3.31165e-06
factor x deficiency [NCBI] 3.26933e-06
PZP [NCBI] 3.26933e-06
TCF7L2 [NCBI] 3.26933e-06
TNFRSF11B [NCBI] 3.25994e-06
GFAP [NCBI] 3.23274e-06
PGR [NCBI] 3.14269e-06
HCRT [NCBI] 3.09792e-06
AANAT [NCBI] 3.09792e-06
lynch syndrome i [NCBI] 3.06562e-06
PWS [NCBI] 3.0212e-06
RP2 [NCBI] 3.01576e-06
NP [NCBI] 3.01576e-06
DKC [NCBI] 3.0131e-06
homocysteinemia [NCBI] 3.0131e-06
graves disease [NCBI] 3.0131e-06
DAO [NCBI] 2.93585e-06
GHR [NCBI] 2.93236e-06
APS1 [NCBI] 2.92252e-06
NPY [NCBI] 2.88296e-06
SOD1 [NCBI] 2.87176e-06
GALT [NCBI] 2.78242e-06
FLNA [NCBI] 2.78242e-06
FMF [NCBI] 2.78133e-06
PD [NCBI] 2.76623e-06
LGMD2C [NCBI] 2.71654e-06
MSH2 [NCBI] 2.637e-06
SLC18A2 [NCBI] 2.637e-06
PLP1 [NCBI] 2.56713e-06
MAG [NCBI] 2.55305e-06
SMA1 [NCBI] 2.52121e-06
PPR [NCBI] 2.47734e-06
ABP1 [NCBI] 2.45414e-06
FCHL [NCBI] 2.44154e-06
IGF2 [NCBI] 2.43272e-06
NR1I2 [NCBI] 2.41954e-06
PSEN1 [NCBI] 2.41801e-06
MAS [NCBI] 2.36244e-06
BWS [NCBI] 2.33858e-06
PGK1 [NCBI] 2.30503e-06
ENPEP [NCBI] 2.30503e-06
AQP4 [NCBI] 2.24357e-06
KRAS [NCBI] 2.24357e-06
LGMD2A [NCBI] 2.18675e-06
SPG3A [NCBI] 2.18675e-06
MMP2 [NCBI] 2.12518e-06
SPTA1 [NCBI] 2.12518e-06
LCN2 [NCBI] 2.12518e-06
APP [NCBI] 2.07895e-06
DNMT1 [NCBI] 2.07895e-06
BIRC1 [NCBI] 2.01252e-06
SOD2 [NCBI] 1.97755e-06
ALD [NCBI] 1.96462e-06
NMU [NCBI] 1.95822e-06
LIPC [NCBI] 1.95822e-06
myoclonic dystonia [NCBI] 1.95095e-06
polycystic kidneys [NCBI] 1.92485e-06
GPT [NCBI] 1.90523e-06
BLM [NCBI] 1.89706e-06
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency [NCBI] 1.89706e-06
CDK4 [NCBI] 1.86399e-06
ADA [NCBI] 1.80335e-06
TFF3 [NCBI] 1.80303e-06
PAX3 [NCBI] 1.75374e-06
CCR5 [NCBI] 1.75374e-06
HIGM1 [NCBI] 1.73301e-06
TBS [NCBI] 1.73301e-06
CDPX2 [NCBI] 1.73301e-06
PCTT [NCBI] 1.73301e-06
meningioma, familial [NCBI] 1.73301e-06
XLP1 [NCBI] 1.73301e-06
sandhoff disease [NCBI] 1.73301e-06
DMD [NCBI] 1.72968e-06
IL10 [NCBI] 1.70561e-06
TSC2 [NCBI] 1.65862e-06
MC4R [NCBI] 1.65862e-06
wilson disease [NCBI] 1.62526e-06
THRB [NCBI] 1.61273e-06
LS [NCBI] 1.60815e-06
POMC [NCBI] 1.58907e-06
LRP1 [NCBI] 1.55485e-06
CMTX1 [NCBI] 1.53192e-06
PXE [NCBI] 1.49235e-06
APOA1 [NCBI] 1.4396e-06
LCAT [NCBI] 1.41759e-06
MTTL1 [NCBI] 1.35894e-06
CHAT [NCBI] 1.35431e-06
SNCA [NCBI] 1.31999e-06
TRPV1 [NCBI] 1.28195e-06
HRG [NCBI] 1.28195e-06
GPI [NCBI] 1.23771e-06
MTHFR [NCBI] 1.20846e-06
apnea, obstructive sleep [NCBI] 1.1768e-06
myoclonic epilepsy of unverricht and lundborg [NCBI] 1.17663e-06
PPARA [NCBI] 1.07159e-06
TRPS2 [NCBI] 1.02077e-06
GBA [NCBI] 9.76519e-07
HLA-A [NCBI] 9.76519e-07
osteogenesis imperfecta, type i [NCBI] 9.71444e-07
breast cancer [NCBI] 9.71444e-07
LBP [NCBI] 9.4636e-07
EIG [NCBI] 9.46064e-07
PNMT [NCBI] 9.45689e-07
MAP2 [NCBI] 9.31808e-07
COL2A1 [NCBI] 9.16897e-07
PTHLH [NCBI] 9.15671e-07
SCA2 [NCBI] 8.78109e-07
EGFR [NCBI] 8.71552e-07
MPZ [NCBI] 8.59999e-07
OPRM1 [NCBI] 8.05711e-07
BMD [NCBI] 7.48949e-07
RSTS [NCBI] 7.48949e-07
HDC [NCBI] 7.3255e-07
ABCB11 [NCBI] 7.28943e-07
AIRE [NCBI] 7.04549e-07
PTGS2 [NCBI] 7.04549e-07
GH1 [NCBI] 6.80732e-07
LMNA [NCBI] 6.57481e-07
hypertelorism with esophageal abnormality and hypospadias [NCBI] 6.56894e-07
NSF [NCBI] 6.34786e-07
HAE [NCBI] 6.31692e-07
GUSB [NCBI] 5.6993e-07
WT1 [NCBI] 5.48096e-07
asthma, susceptibility to [NCBI] 5.45161e-07
MYOC [NCBI] 5.29285e-07
porphyria, acute intermittent [NCBI] 5.26079e-07
AKR1B1 [NCBI] 4.84446e-07
hypogonadotropic hypogonadism [NCBI] 4.7262e-07
ACPP [NCBI] 4.66499e-07
MB [NCBI] 4.55932e-07
FBN1 [NCBI] 4.36205e-07
GAL [NCBI] 4.3236e-07
EDMD [NCBI] 4.31566e-07
MUC1 [NCBI] 4.19765e-07
RBP1 [NCBI] 4.18984e-07
CMT1A [NCBI] 4.04615e-07
ABCC1 [NCBI] 3.93562e-07
SCS [NCBI] 3.47651e-07
SCIDX1 [NCBI] 3.47651e-07
aortic valve disease [NCBI] 3.47651e-07
metachromatic leukodystrophy [NCBI] 3.41286e-07
BRCA1 [NCBI] 3.32328e-07
UCN [NCBI] 3.24765e-07
UCP2 [NCBI] 2.96657e-07
IAPP [NCBI] 2.91026e-07
LPI [NCBI] 2.82779e-07
velocardiofacial syndrome [NCBI] 2.82779e-07
ADM [NCBI] 2.8219e-07
LAM [NCBI] 2.75734e-07
PCD [NCBI] 2.75734e-07
thyroid carcinoma, papillary [NCBI] 2.73863e-07
SCA6 [NCBI] 2.73863e-07
RA [NCBI] 2.6905e-07
DRPLA [NCBI] 2.49719e-07
ESD [NCBI] 2.33112e-07
TP53 [NCBI] 2.32442e-07
ILK [NCBI] 2.19802e-07
KCNH2 [NCBI] 2.19802e-07
neuroblastoma [NCBI] 2.0976e-07
ACP5 [NCBI] 1.96597e-07
MJD [NCBI] 1.92718e-07
HGPS [NCBI] 1.80849e-07
TH [NCBI] 1.59988e-07
FGFR1 [NCBI] 1.59148e-07
hypertrophic neuropathy of dejerine-sottas [NCBI] 1.54932e-07
INSR [NCBI] 1.41008e-07
COMP [NCBI] 1.40258e-07
NIDDM [NCBI] 1.37755e-07
OMP [NCBI] 1.32413e-07
ALK [NCBI] 1.09283e-07
HHT [NCBI] 1.08991e-07
GRA [NCBI] 1.08991e-07
SLE [NCBI] 9.15471e-08
DBI [NCBI] 7.44597e-08
EPOR [NCBI] 7.17672e-08
CCM [NCBI] 7.15752e-08
AMC [NCBI] 7.15752e-08
RDT [NCBI] 6.81916e-08
SST [NCBI] 6.69889e-08
STAT5A [NCBI] 4.2764e-08
ABCB1 [NCBI] 4.2764e-08
SCA7 [NCBI] 4.23439e-08
WS1 [NCBI] 4.23439e-08
hypercholesterolemia, autosomal dominant [NCBI] 4.1983e-08
AHR [NCBI] 4.07398e-08
ACHE [NCBI] 3.95432e-08
GIP [NCBI] 3.55679e-08
FGF2 [NCBI] 2.68007e-08
FRDA [NCBI] 2.63111e-08
IL6 [NCBI] 1.73919e-08
PLK1 [NCBI] 1.47276e-08
TPO [NCBI] 1.29515e-08
CASR [NCBI] 1.00895e-08
BPES [NCBI] 8.34282e-09
CJD [NCBI] 6.9042e-09
dystrophia myotonica 1 [NCBI] 6.43173e-09
MBL2 [NCBI] 5.84016e-09
SLC18A3 [NCBI] 2.61693e-09
CHM [NCBI] 6.38786e-10
WBS [NCBI] 9.55538e-11



Database Center for Life Science